Structure |
Chemical Name |
CAS |
MF |
![Pitavastatin Impurity 61](/) |
Pitavastatin Impurity 61 |
|
|
![Sitafloxacin Impurity 17](/) |
Sitafloxacin Impurity 17 |
|
|
![Cilastatin Isomer Impurity](/) |
Cilastatin Isomer Impurity |
|
|
![Prednicarbate Impurity E](/) |
Prednicarbate Impurity E |
|
|
![Olprinone Impurity B](/) |
Olprinone Impurity B |
|
|
![Canagliflozin Impurity 51](/) |
Canagliflozin Impurity 51 |
|
|
![Canagliflozin Impurity 67](/) |
Canagliflozin Impurity 67 |
|
|
![Cefazolin Impurity Q](/) |
Cefazolin Impurity Q |
|
|
![Cabozantinib impurity M](/) |
Cabozantinib impurity M |
|
|
![Rotigotine Impurity 8](/) |
Rotigotine Impurity 8 |
|
|
![Palbociclib-025](/CAS/20200611/GIF/2174002-16-3.gif) |
Palbociclib-025 |
2174002-16-3 |
C25H29N7O3 |
![Nitrendipine iMpurity 3](/) |
Nitrendipine iMpurity 3 |
|
|
![Cefminox Impurity 3](/) |
Cefminox Impurity 3 |
|
|
![Bosutinib Impurity 15](/) |
Bosutinib Impurity 15 |
|
|
![Ertapenem Impurity 2](/) |
Ertapenem Impurity 2 |
|
|
![Febuxostat Impurity 68](/) |
Febuxostat Impurity 68 |
|
|
![Indacaterol Impurity 9](/) |
Indacaterol Impurity 9 |
|
|
![Olanzapine Impurity 22](/CAS/20200119/GIF/CB04907297.gif) |
Olanzapine Impurity 22 |
|
C17H20N4S |
![Olopatadine Impurity 9](/CAS/20211123/GIF/680579-52-6.gif) |
Olopatadine Impurity 9 |
680579-52-6 |
C39H36Br2P2 |
![Oseltamivir Impurity 59](/CAS/20210305/GIF/2485836-60-8.gif) |
Oseltamivir Impurity 59 |
2485836-60-8 |
C12H22N2O3 |
![Palbociclib Impurity 36](/) |
Palbociclib Impurity 36 |
|
|
![Regorafenib Impurity 34](/) |
Regorafenib Impurity 34 |
|
|
![Rosuvastatin Impurity 47](/) |
Rosuvastatin Impurity 47 |
|
|
![Sildenafil Impurity 36](/CAS/20200119/GIF/CB04907914.gif) |
Sildenafil Impurity 36 |
|
C25H27N3O5 |
![Sunitinib Impurity 4](/) |
Sunitinib Impurity 4 |
|
|
![Tafluprost Impurity 11](/) |
Tafluprost Impurity 11 |
|
|
![Tazobactam Impurity 4](/) |
Tazobactam Impurity 4 |
|
|
![Ticagrelor Impurity 103](/) |
Ticagrelor Impurity 103 |
|
|
![Ticagrelor Impurity 94](/) |
Ticagrelor Impurity 94 |
|
|
![Tofacitinib Impurity 119](/) |
Tofacitinib Impurity 119 |
|
|
![Trelagliptin Impurity 26](/) |
Trelagliptin Impurity 26 |
|
|
![Trelagliptin Impurity 31](/) |
Trelagliptin Impurity 31 |
|
|
![Caspofungin impurity E](/) |
Caspofungin impurity E |
|
|
![Erythromycin Impurity C](/) |
Erythromycin Impurity C |
|
|
![Itraconazole iMpurity 4](/) |
Itraconazole iMpurity 4 |
|
|
![Ozagrel Impurity 2](/) |
Ozagrel Impurity 2 |
|
|
![Olaparib Impurity 22](/) |
Olaparib Impurity 22 |
|
|
![Irbesartan Impurity 14](/CAS/20200119/GIF/CB04918833.gif) |
Irbesartan Impurity 14 |
133690-91-2 |
C25H28N6O |
![Febuxostat Impurity 25](/CAS/20211123/GIF/1643131-89-8.gif) |
Febuxostat Impurity 25 |
1643131-89-8 |
C17H20N2O4S |
![Pregabalin Impurity 3](/CAS/20211123/GIF/1928754-83-9.gif) |
Pregabalin Impurity 3 |
1928754-83-9 |
C12H22O3 |
![Bosutinib Impurity 6](/) |
Bosutinib Impurity 6 |
|
|
![Ticagrelor Impurity 49](/) |
Ticagrelor Impurity 49 |
2376278-80-5 |
|
![Edoxaban Impurity 14](/) |
Edoxaban Impurity 14 |
|
|
![Indacaterol Impurity 3](/CAS/20210305/GIF/2250243-41-3.gif) |
Indacaterol Impurity 3 |
2250243-41-3 |
C26H32N2O3 |
![Canagliflozin Impurity 11](/) |
Canagliflozin Impurity 11 |
|
|
![Oseltamivir Impurity 22](/) |
Oseltamivir Impurity 22 |
|
|
![Riociguat IMpurtiy B](/) |
Riociguat IMpurtiy B |
|
|
![Silodosin Impurity C](/) |
Silodosin Impurity C |
|
|
![Dexmedetomidine-025](/CAS/20200611/GIF/2250242-52-3.gif) |
Dexmedetomidine-025 |
2250242-52-3 |
C20H22N2 |
![pranoprofen impurity 15](/) |
pranoprofen impurity 15 |
|
|
![Mono-Hydroxy Sugammadex](/CAS/20211123/GIF/2376607-99-5.gif) |
Mono-Hydroxy Sugammadex |
2376607-99-5 |
C69H109NaO47S7 |
![Metronidazole impurity A](/) |
Metronidazole impurity A |
|
|
![Sulpiride Impurity 6](/) |
Sulpiride Impurity 6 |
|
|
![Cefminox Impurity A](/) |
Cefminox Impurity A |
|
|
![Cefminox Impurity F](/) |
Cefminox Impurity F |
|
|
![IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE)](/CAS/20180808/GIF/748812-53-5.gif) |
IRBESARTAN RELATED COMPOUND A (25 MG) (1-PENTANOYLAMINO-CYCLOPENTANECARBOXYLIC ACID [2'-(1H-TETRAZOL-5-YL)-BIPHENYL-4-YLMETHYL]-AMIDE) |
748812-53-5 |
C25H30N6O2 |
![FENOFIBRATE RELATED COMPOUND C (25 MG) (1-METHYLETHYL 2-[[2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPANOYL]OXY]-2-METHYLPROPANOATE)](/CAS/GIF/217636-48-1.gif) |
FENOFIBRATE RELATED COMPOUND C (25 MG) (1-METHYLETHYL 2-[[2-[4-(4-CHLOROBENZOYL)PHENOXY]-2-METHYLPROPANOYL]OXY]-2-METHYLPROPANOATE) |
217636-48-1 |
C24H27ClO6 |
![(S-(R* S*))-(+)-N-(1-PHENYLETHYL)-1- AZ&](/CAS/GIF/120570-09-4.gif) |
(S-(R* S*))-(+)-N-(1-PHENYLETHYL)-1- AZ& |
120570-09-4 |
C15H24Cl2N2 |
![VERAPAMIL RELATED COMPOUND B (50 MG) (AL-PHA-[2-[[2-(3,4-DIMETHOXYPHENYL)-ETHYL]METHYLA-MINO]ETHYL]-3,4-DIMETHOXY-ALPHA-(1-METHY-LETHYL)-BENZENEACETONITRILE MONOHYDROCHLORIDE)](/CAS/GIF/1794-55-4.gif) |
VERAPAMIL RELATED COMPOUND B (50 MG) (AL-PHA-[2-[[2-(3,4-DIMETHOXYPHENYL)-ETHYL]METHYLA-MINO]ETHYL]-3,4-DIMETHOXY-ALPHA-(1-METHY-LETHYL)-BENZENEACETONITRILE MONOHYDROCHLORIDE) |
1794-55-4 |
C26H37ClN2O4 |
![N-(5-(Propionyloxy)pentyl Acrylate) rac-trans-Laudanosine Benzenesulfonate](/CAS/20210111/GIF/155913-32-9.gif) |
N-(5-(Propionyloxy)pentyl Acrylate) rac-trans-Laudanosine Benzenesulfonate |
155913-32-9 |
C38H49NO11S |
![1,8-ditosyl-1,4,8,11-tetraazacyclotetradecane dihydrochloride](/CAS/20200119/GIF/CB05417124.gif) |
1,8-ditosyl-1,4,8,11-tetraazacyclotetradecane dihydrochloride |
|
C24H38Cl2N4O4S2 |
![Mupirocin iMpurity 5](/CAS/20200119/GIF/CB05417654.gif) |
Mupirocin iMpurity 5 |
|
C26H44O9 |
![Tolvaptan Impurity 11](/CAS/20200611/GIF/150683-27-5.gif) |
Tolvaptan Impurity 11 |
150683-27-5 |
C25H23ClN2O3 |
![methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate](/CAS/20210305/GIF/1638785-19-9.gif) |
methyl 2-(4-(2-chloroacetyl)phenyl)-2-methylpropanoate |
1638785-19-9 |
C13H15ClO3 |
![1155863-81-2](/CAS/20210111/GIF/1155863-81-2.gif) |
1155863-81-2 |
1155863-81-2 |
C23H19F2N3O6 |
![1175018-73-1](/CAS/20210111/GIF/1175018-73-1.gif) |
1175018-73-1 |
1175018-73-1 |
C12H14ClN |
![Clopidogrel Impurity 44](/CAS/20200331/GIF/CB05430813.gif) |
Clopidogrel Impurity 44 |
|
C15H14ClNO2S |
![5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate](/CAS/20200331/GIF/949155-13-9.gif) |
5-ethyl 7-methyl 6-(2-chlorophenyl)-8-methyl-3,4,5,6-tetrahydro-2H- benzo[b][1,4]oxazine-5,7-dicarboxylate |
949155-13-9 |
C20H22ClNO5 |
![Nifedipine impurity 06](/CAS/20200119/GIF/CB05432291.gif) |
Nifedipine impurity 06 |
|
C19H22N2O6 |
![Moxifloxacin Impurity 10](/) |
Moxifloxacin Impurity 10 |
|
|
![Ticagrelor Impurity 11](/) |
Ticagrelor Impurity 11 |
|
|
![Parecoxib Impurity 18](/) |
Parecoxib Impurity 18 |
|
|
![Teneligliptin Impurity 9 DiHCl](/) |
Teneligliptin Impurity 9 DiHCl |
|
|
![Pramipexole Impurity Z2](/) |
Pramipexole Impurity Z2 |
|
|
![1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl-](/CAS/20200119/GIF/962-95-8.gif) |
1-Propanamine, 3-(diphenylphosphinyl)-N,N-dimethyl- |
962-95-8 |
C17H22NOP |
![Cabozantinib Impurity 50](/CAS/20210111/GIF/202917-05-3.gif) |
Cabozantinib Impurity 50 |
202917-05-3 |
C17H14N2O5 |
![Landiolol impurity U](/) |
Landiolol impurity U |
|
|
![Teneligliptin Impurity 15](/) |
Teneligliptin Impurity 15 |
|
|
![Nicergoline EP Impurity I](/) |
Nicergoline EP Impurity I |
|
|
![Carbamic acid, N-[(4-methylphenyl)sulfonyl]-](/CAS/20200331/GIF/107628-27-3.gif) |
Carbamic acid, N-[(4-methylphenyl)sulfonyl]- |
107628-27-3 |
C8H9NO4S |
![9H-Purin-6-amine, 9-(2-chloropropyl)-](/CAS/20200119/GIF/50615-40-2.gif) |
9H-Purin-6-amine, 9-(2-chloropropyl)- |
50615-40-2 |
C8H10ClN5 |
![Hyoscine Butylbromide EP Impurity G](/) |
Hyoscine Butylbromide EP Impurity G |
|
|
![Cinacalcet Impurity 38 HCl](/CAS/20211123/GIF/938177-81-2.gif) |
Cinacalcet Impurity 38 HCl |
938177-81-2 |
C21H24ClN |
![Norepinephrine Impurity 23](/CAS/20200119/GIF/1528622-09-4.gif) |
Norepinephrine Impurity 23 |
1528622-09-4 |
C9H13NO3 |
![Brexpiprazole Impurity 77](/CAS/20210111/GIF/1783311-11-4.gif) |
Brexpiprazole Impurity 77 |
1783311-11-4 |
C12H14N2S |
![(S)-1-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol](/CAS/20200119/GIF/114218-35-8.gif) |
(S)-1-(isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol |
114218-35-8 |
C15H26ClNO3 |
![1-Pentanone, 1-(2-hydroxy-5-methylphenyl)-](/CAS/20200331/GIF/150033-77-5.gif) |
1-Pentanone, 1-(2-hydroxy-5-methylphenyl)- |
150033-77-5 |
C12H16O2 |
![PLSQ-001 TM4-QJ](/CAS/20200611/GIF/1227162-74-4.gif) |
PLSQ-001 TM4-QJ |
1227162-74-4 |
C18H24N2O2 |
![(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid](/CAS/20200331/GIF/CB05559992.gif) |
(2S)-2-(2,5-dioxo-3-propylpyrrolidin-1-yl)butanoic acid |
2101641-92-1 |
C11H17NO4 |
![2-Pyridineethanamine, N-methyl-N-[2-(2-pyridinyl)ethyl]-, hydrochloride (1:3)](/CAS/20211123/GIF/2095467-43-7.gif) |
2-Pyridineethanamine, N-methyl-N-[2-(2-pyridinyl)ethyl]-, hydrochloride (1:3) |
2095467-43-7 |
C15H20ClN3 |
![Droxidopa Impurity 4](/CAS/20210305/GIF/55382-14-4.gif) |
Droxidopa Impurity 4 |
55382-14-4 |
C31H29NO7 |
![(1r,4r)-4-(5,6-dibromo-2-methylquinazolin-3(4H)-yl)cyclohexan-1-ol](/) |
(1r,4r)-4-(5,6-dibromo-2-methylquinazolin-3(4H)-yl)cyclohexan-1-ol |
|
|
![Dapagliflozin Impurity (MW:423Da)](/) |
Dapagliflozin Impurity (MW:423Da) |
|
|
![Ramipril - Isomer Impurity 1](/) |
Ramipril - Isomer Impurity 1 |
|
|
![Aripiprazole peroxide degradation Impurity (MW:480Da)](/) |
Aripiprazole peroxide degradation Impurity (MW:480Da) |
|
|
![Fosinopril Sodium Impurity A (Fosinoprilat)](/) |
Fosinopril Sodium Impurity A (Fosinoprilat) |
|
|
![Dapoxetine Impurity 40](/) |
Dapoxetine Impurity 40 |
|
|
![Doxofylline Impurity 15](/) |
Doxofylline Impurity 15 |
|
|
![Iohexol Impurity 10](/) |
Iohexol Impurity 10 |
|
|
![Benzylpenicillin EP(CP) Impurity F](/) |
Benzylpenicillin EP(CP) Impurity F |
|
|